Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleIMAGING

Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases

Elahe Pirayesh, Mahasti Amoui, Hamid Reza Mirzaee, Faraj Tabei, Afshin Rakhsha, Bagher Aziz Kalantari, Babak Shafiei, Majid Assadi and Isa Neshandar Asli
Journal of Nuclear Medicine Technology September 2013, 41 (3) 192-196; DOI: https://doi.org/10.2967/jnmt.113.124297
Elahe Pirayesh
1Department of Nuclear Medicine, Shohada-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahasti Amoui
1Department of Nuclear Medicine, Shohada-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamid Reza Mirzaee
2Department of Radiation Oncology, Shohada-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faraj Tabei
4Department of Nuclear Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afshin Rakhsha
2Department of Radiation Oncology, Shohada-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bagher Aziz Kalantari
5Karaj Branch, Azad University, Karaj, Iran; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Babak Shafiei
4Department of Nuclear Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Majid Assadi
6Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isa Neshandar Asli
4Department of Nuclear Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 3 192-196
DOI 
https://doi.org/10.2967/jnmt.113.124297
PubMed 
23918612

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication April 2, 2013
  • Accepted for publication July 12, 2013
  • Published online September 4, 2013.

Article Versions

  • previous version (August 5, 2013 - 05:31).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Elahe Pirayesh1,
  2. Mahasti Amoui1,
  3. Hamid Reza Mirzaee2,3,
  4. Faraj Tabei4,
  5. Afshin Rakhsha2,
  6. Bagher Aziz Kalantari5,
  7. Babak Shafiei4,
  8. Majid Assadi6 and
  9. Isa Neshandar Asli4
  1. 1Department of Nuclear Medicine, Shohada-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2Department of Radiation Oncology, Shohada-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4Department of Nuclear Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5Karaj Branch, Azad University, Karaj, Iran; and
  6. 6Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
  1. For correspondence or reprints contact: Majid Assadi, Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr 3631, Iran. E-mail: assadipoya{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 14 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline
    Stephen Lutz, Tracy Balboni, Joshua Jones, Simon Lo, Joshua Petit, Shayna E. Rich, Rebecca Wong, Carol Hahn
    Practical Radiation Oncology 2017 7 1
  • Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain
    Reyhaneh Manafi-Farid, Fardad Masoumi, Ghasemali Divband, Bahare Saidi, Bahar Ataeinia, Fabian Hertel, Gregor Schweighofer-Zwink, Agnieszka Morgenroth, Mohsen Beheshti
    Journal of Clinical Medicine 2020 9 8
  • Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons
    Tapas Das, Sharmila Banerjee
    Clinical & Experimental Metastasis 2017 34 1
  • Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
    Ana M. Denis-Bacelar, Sarah J. Chittenden, David P. Dearnaley, Antigoni Divoli, Joe M. O’Sullivan, V. Ralph McCready, Bernadette Johnson, Yong Du, Glenn D. Flux
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 4
  • Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology

    Jeannine Brant, Lisa Keller, Karen McLeod, Chao Hsing Yeh, Linda Eaton
    Clinical Journal of Oncology Nursing 2017 21 3
  • Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
    Ashutosh Dash, Tapas Das, Furn F. Russ Knapp
    Current Medicinal Chemistry 2020 27 19
  • Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran
    Amir Reza Jalilian, Davood Beiki, Arman Hassanzadeh-Rad, Arash Eftekhari, Parham Geramifar, Mohammad Eftekhari
    Seminars in Nuclear Medicine 2016 46 4
  • Evaluation of 153Sm/177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent
    Hassan Ranjbar, Ali Bahrami-Samani, Davood Beiki, Simindokht Shirvani-Arani, Mohammad Ghannadi-Maragheh
    Journal of Radioanalytical and Nuclear Chemistry 2015 303 1
  • Simulation study on the production of medical radioisotopes 186gRe by photonuclear reaction
    Y.X. Yang, W.J. Zhao, X.G. Cao, H.W. Wang, G.T. Fan, L.X. Liu, H.H. Xu, X.R. Hu, X.X. Li, Z.R. Hao, S. Jin, K.J. Chen, Y.G. Ma
    Radiation Physics and Chemistry 2024 218
  • Appraisement of 186/188Re-HEDP, a new compositional radiopharmaceutical
    Zahra Pourhabib, Hassan Ranjbar, Ali Bahrami Samani, Ali Asghar Shokri
    Journal of Radioanalytical and Nuclear Chemistry 2019 322 2

Article usage

Article usage: August 2013 to April 2025

AbstractFullPdf
Aug 20138203
Sep 2013268619
Oct 2013264110
Nov 2013166918
Dec 20136663
Jan 20145655
Feb 2014781011
Mar 2014671410
Apr 2014591511
May 201473416
Jun 201464811
Jul 20142868
Aug 201445710
Sep 201454910
Oct 2014471419
Nov 2014141616
Dec 201424311
Jan 201541613
Feb 201514610
Mar 20153386
Apr 20152064
May 20153096
Jun 201528119
Jul 2015191215
Aug 20154779
Sep 20158286
Oct 20152378
Nov 20151636
Dec 20152564
Jan 2016361715
Feb 2016231311
Mar 2016231413
Apr 2016171411
May 201631147
Jun 20162993
Jul 201632134
Aug 201633147
Sep 201625188
Oct 20162757
Nov 20164520129
Dec 201612999160
Jan 20174314188
Feb 2017371411
Mar 2017261322
Apr 201719916
May 201731813
Jun 20172163
Jul 201722712
Aug 20172477
Sep 20171976
Oct 20171554
Nov 201735139
Dec 20171253
Jan 20182563
Feb 20182345
Mar 20182563
Apr 201817104
May 20181121
Jun 20181223
Jul 201819434
Aug 20181010
Sep 20181786
Oct 2018831
Nov 20181465
Dec 2018411
Jan 20191134
Feb 20191107
Mar 2019555
Apr 20191034
May 20195113
Jun 2019436
Jul 2019713
Aug 20191239
Sep 20191222
Oct 20192139
Nov 20191353
Dec 20191122
Jan 2020533
Feb 20201376
Mar 20201525
Apr 20201011
May 2020813
Jun 20201441
Jul 20201123
Aug 20201903
Sep 20201321
Oct 20202916
Nov 20201236
Dec 2020414
Jan 2021516
Feb 202171219
Mar 2021787
Apr 2021442
May 2021395
Jun 20217105
Jul 2021669
Aug 202182119
Sep 202191310
Oct 202131325
Nov 2021111326
Dec 202131613
Jan 202232914
Feb 20224249
Mar 2022586
Apr 20223152
May 202225617
Jun 20222305
Jul 20222145
Aug 20224102
Sep 20228178
Oct 202261312
Nov 20222144
Dec 2022252
Jan 20232910
Feb 20232124
Mar 2023482
Apr 20238166
May 202312185
Jun 20235123
Jul 2023676
Aug 202391313
Sep 202310196
Oct 202312226
Nov 202383611
Dec 2023138218
Jan 2024512188
Feb 2024122410
Mar 202432073
Apr 202431820
May 2024155316
Jun 2024193213
Jul 2024121410
Aug 2024113219
Sep 202493621
Oct 2024133321
Nov 2024122514
Dec 202412318
Jan 202552020
Feb 202545414
Mar 202556716
Apr 2025124273
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 41 (3)
Journal of Nuclear Medicine Technology
Vol. 41, Issue 3
September 1, 2013
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases
Elahe Pirayesh, Mahasti Amoui, Hamid Reza Mirzaee, Faraj Tabei, Afshin Rakhsha, Bagher Aziz Kalantari, Babak Shafiei, Majid Assadi, Isa Neshandar Asli
Journal of Nuclear Medicine Technology Sep 2013, 41 (3) 192-196; DOI: 10.2967/jnmt.113.124297

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases
Elahe Pirayesh, Mahasti Amoui, Hamid Reza Mirzaee, Faraj Tabei, Afshin Rakhsha, Bagher Aziz Kalantari, Babak Shafiei, Majid Assadi, Isa Neshandar Asli
Journal of Nuclear Medicine Technology Sep 2013, 41 (3) 192-196; DOI: 10.2967/jnmt.113.124297
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Robustness of 18F-FDG PET Radiomic Features in Lung Cancer: Impact of Advanced Reconstruction Algorithm
Show more Imaging

Similar Articles

Keywords

  • rhenium 186(tin) etidronate
  • pain palliation
  • bone metastasis
SNMMI

© 2025 SNMMI

Powered by HighWire